Literature DB >> 24908664

Late gadolinium enhancement assessed by cardiac magnetic resonance imaging in heart transplant recipients with different stages of cardiac allograft vasculopathy.

Maria Fernanda Braggion-Santos1, Dirk Lossnitzer2, Sebastian Buss2, Stephanie Lehrke3, Andreas Doesch2, Evangelos Giannitsis2, Grigorios Korosoglou2, Hugo A Katus2, Henning Steen4.   

Abstract

AIMS: Cardiac allograft vasculopathy (CAV), which limits long-term survival after heart transplantation (HTX), is usually evaluated by coronary angiography (CA). Late gadolinium enhancement cardiac magnetic resonance (LGE-CMR) is a non-invasive technique that can detect CAV-related myocardial infarctions. We aimed to investigate the presence of LGE infarct-typical patterns in a large sample of HTX recipients and to correlate these findings with the severity of CAV assessed by CA. METHODS AND
RESULTS: LGE-CMR was performed in 132 HTX patients on a 1.5-T MRI scanner (Philips, Best, the Netherlands). Infarct-typical LGE areas were identified as bright lesions with subendocardial involvement. Infarct-atypical LGE was classified as follows: (i) right ventricle (RV) insertion, (ii) intramural, (iii) epicardial, and (iv) diffuse. CA was performed for the assessment of CAV (CAV0 = no lesion, CAV1 = mild lesions, CAV2 = moderate lesions, CAV3 = severe lesions, or mild/moderate lesions with allograft dysfunction). Infarct-typical LGE patterns were detected in 29 (22%) patients distributed in all groups and they were already present in nearly every fifth CAV0 patient, increasing significantly among CAV groups (CAV0 = 19%, CAV1 = 10%, CAV2 = 36%, and CAV3 = 71%; P < 0.01).
CONCLUSION: LGE-CMR was useful to identify myocardial scar possibly related to early CAV in a significant proportion of HTX recipients, otherwise classified as low-risk patients based on CA. Therefore, LGE-CMR could be helpful to intensify CAV monitoring, medical therapy, and clinical risk stratification. Published on behalf of the European Society of Cardiology. All rights reserved.
© The Author 2014. For permissions please email: journals.permissions@oup.com.

Entities:  

Keywords:  Cardiac allograft vasculopathy; Cardiac magnetic resonance; Heart transplantation; Late gadolinium enhancement

Mesh:

Substances:

Year:  2014        PMID: 24908664     DOI: 10.1093/ehjci/jeu090

Source DB:  PubMed          Journal:  Eur Heart J Cardiovasc Imaging        ISSN: 2047-2404            Impact factor:   6.875


  8 in total

1.  Myocardial tissue remodeling after orthotopic heart transplantation: a pilot cardiac magnetic resonance study.

Authors:  Otavio Rizzi Coelho-Filho; Ravi Shah; Carlos Fernando Ramos Lavagnoli; Jose Carlos Barros; Tomas G Neilan; Venkatesh L Murthy; Pedro Paulo Martins de Oliveira; Jose Roberto Matos Souza; Elaine Soraya Barbosa de Oliveira Severino; Karlos Alexandre de Souza Vilarinho; Lindemberg da Mota Silveira Filho; Jose Garcia; Marc J Semigran; Otavio Rizzi Coelho; Michael Jerosch-Herold; Orlando Petrucci
Journal:  Int J Cardiovasc Imaging       Date:  2016-07-20       Impact factor: 2.357

Review 2.  Imaging in patients after cardiac transplantation and in patients with ventricular assist devices.

Authors:  Bhanu Gupta; Dany Jacob; Randall Thompson
Journal:  J Nucl Cardiol       Date:  2015-04-02       Impact factor: 5.952

3.  Myocardial Fibrosis and Prognosis in Heart Transplant Recipients.

Authors:  Andrew Hughes; Osama Okasha; Afshin Farzaneh-Far; Felipe Kazmirczak; Prabhjot S Nijjar; Pratik Velangi; Mehmet Akçakaya; Cindy M Martin; Chetan Shenoy
Journal:  Circ Cardiovasc Imaging       Date:  2019-10-15       Impact factor: 7.792

Review 4.  Multi-modal imaging of the pediatric heart transplant recipient.

Authors:  Jonathan H Soslow; Margaret M Samyn
Journal:  Transl Pediatr       Date:  2019-10

5.  Myocardial perfusion reserve and global longitudinal strain as potential markers of coronary allograft vasculopathy in late-stage orthotopic heart transplantation.

Authors:  Akhil Narang; John E Blair; Mita B Patel; Victor Mor-Avi; Savitri E Fedson; Nir Uriel; Roberto M Lang; Amit R Patel
Journal:  Int J Cardiovasc Imaging       Date:  2018-05-04       Impact factor: 2.357

6.  Assessment of sympathetic reinnervation after cardiac transplantation using hybrid cardiac PET/MRI: A pilot study.

Authors:  Dietrich Beitzke; Alice Wielandner; Tim Wollenweber; Chrysoula Vraka; Verena Pichler; Keziban Uyanik-Uenal; Andreas Zuckermann; Andreas Greiser; Marcus Hacker; Christian Loewe
Journal:  J Magn Reson Imaging       Date:  2019-03-20       Impact factor: 4.813

7.  Multi-parametric cardiovascular magnetic resonance with regadenoson stress perfusion is safe following pediatric heart transplantation and identifies history of rejection and cardiac allograft vasculopathy.

Authors:  Nazia Husain; Kae Watanabe; Haben Berhane; Aditi Gupta; Michael Markl; Cynthia K Rigsby; Joshua D Robinson
Journal:  J Cardiovasc Magn Reson       Date:  2021-11-22       Impact factor: 5.364

8.  Case Report: Early Transplant Rejection of a Methanol-Intoxicated Donor Heart in a Young Female Patient. A Diagnostic Approach With CMR, Cardiac Biopsy, and Genetic Risk Assessment.

Authors:  Lukas Stoiber; Felix Schoenrath; Christoph Knosalla; Hendrik Milting; Karin Klingel; Carsten Tschöpe; Radu Tanacli; Rolf Gebker; Alexander Berger; Burkert Pieske; Sebastian Kelle
Journal:  Front Immunol       Date:  2021-02-22       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.